country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-182405

Copy Link Print Information

GQ127

GQ127 is an orally active Gαq/11 inhibitor with an IC₅₀ of 22.6 μM. GQ127 binds directly to Gαq/11 protein and inhibits its activity. GQ127 induces Apoptosis, suppresses viability, migration and invasion of uveal melanoma cells. GQ127 increases the phosphorylation level of YAP and decreases the phosphorylation level of ERK. GQ127 inhibits the growth of uveal melanoma xenografts in mouse models. GQ127 can be used for research related to uveal melanoma.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 2625582-70-7
Formel: C₂₅H₃₆N₄O
Molecular Weight:408.58

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

GQ127 Chemical Structure

CAS. Nr.: 2625582-70-7

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- Cellular Effect
- In Vitro
- Parmacokinetics
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

Alle YAP Isoform-spezifische Produkte anzeigen :

Alle ERK Isoform-spezifische Produkte anzeigen :

Cellular Effect

Cell Line	Type	Value	Description	References
MP41	IC₅₀	24.8 μM Compound: GQ127	Antiproliferative activity against human MP41 cells assessed as inhibition of cell growth after 72 hrs by CCK8 assay Antiproliferative activity against human MP41 cells assessed as inhibition of cell growth after 72 hrs by CCK8 assay	[PMID: 33715360]

In Vitro

GQ127 (10 μM) potently inhibits Gαq/11-mediated IP1 accumulation in CHO-M₁ cells, with an IC₅₀ of 22.6 μM^[1].
GQ127 potently inhibits the proliferation of UM 92.1 cells (IC₅₀ = 10.1 μM) and MP41 cells (IC₅₀ = 24.8 μM) in a time- and dose-dependent manner^[1].
GQ127 (1.25-20 μM; 24 h) exhibits low cytotoxicity against CHO-M₁ cells, with no reduction in cell viability observed after 24 h of treatment at concentrations below 20 μM^[1].
GQ127 (5-30 μM; 48 h) induces apoptosis in UM 92.1 and MP41 cells in a dose-dependent manner^[1].
GQ127 (5-30 μM; 48 h) significantly inhibits the migration of UM 92.1 and MP41 cells after treatment at concentrations of 15 μM and higher for 48 h^[1].
GQ127 (5-30 μM; 48 h) inhibits Gαq/11-mediated tumorigenesis in UM 92.1 and MP41 cells by increasing the phosphorylation level of YAP and decreasing the phosphorylation level of ERK^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis^[1]

Cell Line:

uveal melanoma (UM) 92.1 cells, uveal melanoma (UM) MP41 cells
Concentration:

5 μM, 15 μM (92.1 cells); 15 μM, 30 μM (MP41 cells)
Incubation Time:

48 h
Result:

Induced apoptosis of 92.1 cells at rates of 9.48% (5 μM) and 20.1% (15 μM).
Induced apoptosis of MP41 cells at rates of 9.74% (15 μM) and 24.1% (30 μM).
Exhibited a dose-dependent apoptotic effect.

Western Blot Analysis^[1]

Cell Line:

uveal melanoma (UM) 92.1 cells, uveal melanoma (UM) MP41 cells
Concentration:

5 μM, 15 μM (92.1 cells); 15 μM, 30 μM (MP41 cells)
Incubation Time:

48 h
Result:

Enhanced the phosphorylation level of YAP in both 92.1 and MP41 cells at 15 μM and 30 μM.
Inhibited the phosphorylation level of ERK in both 92.1 and MP41 cells at 15 μM and 30 μM.

Parmacokinetics

Species	Dose	Route	T_1/2	T_max	C_max	AUC_0-t	MRT_0-t	V_ss	CL	F
Mice^[1]	10 mg/kg	i.v.	1.17 h	0.08 h	2608 ng/mL	2136 ng·h/mL	0.93 h	4.53 L/kg	77.9 mL/min/kg	/
Mice^[1]	30 mg/kg	p.o.	1.41 h	0.42 h	2888 ng/mL	5936 ng·h/mL	1.88 h	/	/	92.6 %

In Vivo

GQ127 (10-30 mg/kg; i.p.; daily; 21 days) exhibits robust dose-dependent antitumor activity in MP41 uveal melanoma xenografts, with a 99.0% TGI at 30 mg/kg and a 65.4% TGI at 10 mg/kg, while showing no severe systemic toxicity^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

BALB/c nude (nu/nu) (male and female, 6−8 weeks old, 20−25 g, subcutaneous MP41 uveal melanoma patient-derived xenograft model)^[1]
Dosage:

10 mg/kg; 30 mg/kg
Administration:

i.p.; daily; 21 days
Result:

Achieved a tumor growth inhibition (TGI) of 99.0% at 30 mg/kg.
Achieved a TGI of 65.4% at 10 mg/kg.
Caused no significant changes in mouse body weight during treatment.
Induced no obvious morphological changes in heart, liver, spleen, lung, or kidney tissues via H&E staining.
Promoted phosphorylation of YAP and inhibited phosphorylation of ERK in tumor tissues at both doses.

Chemical Information

CAS. Nr. 2625582-70-7
Molecular Weight 408.58
Formel C₂₅H₃₆N₄O
SMILES

CC[C@@H](C)[C@H](N)C(N1CCN2C([C@@H]1CC3CCCCC3)=NC(C4=CC=CC=C4)=C2)=O
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Ge Y, et al. Design, Synthesis, and Evaluation of Small Molecule Gαq/11 Protein Inhibitors for the Treatment of Uveal Melanoma. J Med Chem. 2021;64(6):3131-3152. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen

Amount: USD 0.00

Biologische Aktivität
- Beschreibung
- In Vitro
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

GQ127

Alle YAP Isoform-spezifische Produkte anzeigen

Alle ERK Isoform-spezifische Produkte anzeigen

Biologische Aktivität

Chemical Information

Reinheit & Dokumentation

Verweise

Calculators

Help & FAQs

GQ127 Related Classifications

HY-182405 Related Classifications